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Monocytes are able to undergo homotypic fusion to produce different types of multi­
nucleated giant cells, such as Langhans giant cells in response to M. tuberculosis infec­
tion or foreign body giant cells in response to implanted biomaterials. Monocyte fusion 
is highly coordinated and complex, with various soluble, intracellular, and cell­surface 
components mediating different stages of the process. Tetraspanins, such as CD9, 
CD63, and CD81, are known to be involved in cell:cell fusion and have been suggested 
to play a role in regulating homotypic monocyte fusion. However, peripheral human 
monocytes are not homogenous: they exist as a heterogeneous population consisting 
of three subsets, classical (CD14++CD16−), intermediate (CD14++CD16+), and non­ 
classical (CD14+CD16+), at steady state. During infection with mycobacteria, the circulat­
ing populations of intermediate and non­classical monocytes increase, suggesting they 
may play a role in the disease outcome. Human monocytes were separated into subsets 
and then induced to fuse using concanavalin A. The intermediate monocytes were able 
to fuse faster and form signiicantly larger giant cells than the other subsets. When 
antibodies targeting tetraspanins were added, the intermediate monocytes responded 
to anti­CD63 by forming smaller giant cells, suggesting an involvement of tetraspanins in 
fusion for at least this subset. However, the expression of fusion­associated tetraspanins 
on monocyte subsets did not correlate with the extent of fusion or with the inhibition by 
tetraspanin antibody. We also identiied a CD9High and a CD9Low monocyte population 
within the classical subset. The CD9High classical monocytes expressed higher levels of 
tetraspanin CD151 compared to CD9Low classical monocytes but the CD9High classical 
subset did not exhibit greater potential to fuse and the role of these cells in immunity 
remains unknown. With the exception of dendrocyte­expressed seven transmembrane 
protein, which was expressed at higher levels on the intermediate monocyte subset, 
the expression of fusion­related proteins between the subsets did not clearly correlate 
with their ability to fuse. We also did not observe any clear correlation between giant cell 
formation and the expression of pro­inlammatory or fusogenic cytokines. Although tet­
raspanin expression appears to be important for the fusion of intermediate monocytes, 
the control of multinucleate giant cell formation remains obscure.
Keywords: monocyte, tetraspanin, cd9, fusion, monocyte subsets
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inTrODUcTiOn
Human monocytes are able to migrate from the bloodstream into 
the tissues and diferentiate into macrophages and monocyte-
derived dendritic cells (1). hey are important in defense against 
various pathogens (2) but are also implicated in autoimmune and 
inlammatory diseases (3). Blood monocytes are heterogeneous 
and three subsets have been deined: classical (Cl, CD14++CD16−), 
intermediate (Int, CD14++CD16+), and non-classical (NCl, 
CD14+CD16+), comprising ~85, 5, and 10% of the total, respec-
tively (3, 4). Investigation of the maturation and diferentiation 
kinetics of labeled human monocytes in vivo suggests that they 
mature from Cl to Int and then to NCl (5, 6). he subsets difer in 
their gene expression proiles, cell surface markers, and cytokine 
secretion (7–11). he blood populations of the Int and NCl have 
been observed to be increased in patients with tuberculosis (12) 
and rheumatoid arthritis (13), whereas Int numbers are increased 
in various other inlammatory conditions, including Crohn’s 
disease (14), sarcoidosis (15), and cardiac disease (16, 17).
Under certain circumstances, monocytes and macrophages 
are able to fuse to form multinucleated giant cells (MGC), 
such as the osteoclast MGC that remodel and maintain bone 
homeostasis (18). Monocytes can form inlammatory MGC, 
such as Langhans giant cells (LGC), in response to M. tuber-
culosis infections during granuloma formation around infected 
macrophages (19). Monocytes can also fuse in response to 
non-phagocytosable foreign material such as medical implants, 
forming foreign body giant cells (FBGC) (20).
he mechanism of monocyte fusion is still largely unknown 
and only a handful of essential proteins have been identiied 
(21, 22). Furthermore, LGC and FBGC formation appears to be 
initiated by diferent cytokines, IFNγ and IL-4, respectively, which 
could suggest that they coordinate fusion through multiple signal 
transduction pathways (23, 24). Monocytes activated by fusogenic 
stimuli secrete chemokines, such as CCL2 and CCL3, upregulate 
cell–cell adhesion proteins (LFA-1, ICAM-1, and E-cadherin) 
(25) and fusion-facilitating proteins, such as CD200 (26), SIRPα/
CD172a/MFR (27), CD47 (28), CD36 (29), CD62E (E-selectin) 
(30), matrix metallopeptidase 9 (MMP9) (31), and dendrocyte-
expressed seven transmembrane protein (DC-STAMP) (32, 33).
he tetraspanin family of membrane proteins has been impli-
cated in the regulation of several diferent types of cell–cell fusion, 
including CD9, CD81, and CD151 in sperm–egg interactions 
(34), CD9 and CD81 in muscle cell fusion (35), CD82 in HTLV-1 
syncytial formation (36) and CD9 in HIV-1-induced cell fusion 
(37). Osteoclast formation is known to be regulated by CD9, 
Tspan-5, and Tspan13 (38, 39). In experimental systems using 
concanavalin A (ConA)-induced fusion, anti-tetraspanin anti-
bodies against CD9, CD81, CD151, and CD63 have been shown 
to inhibit or enhance the formation of MGC (40–42). Importantly, 
many of the fusion regulatory proteins implicated in MGC forma-
tion have been shown to be associated with tetraspanins in the 
plasma membrane (43).
Recently, CD9, CD53, CD63, and CD81 were shown to be 
expressed diferently on the three monocyte subsets (44), indicat-
ing that subsets may have diferent fusion behaviors. In this study, 
we have investigated the propensities of the monocyte subsets 
for fusion, and attempted to correlate this with the expression 
of a group of fusion-related tetraspanins, fusion proteins, and 
cytokines. Further understanding of the contribution of mono-
cyte subsets to fusion and the role tetraspanins play in the fusion 
process may help develop treatments for granulomatous diseases 
such as tuberculosis and inhibit foreign body reactions during 
medical implant rejection.
MaTerials anD MeThODs
cells
All experiments used human blood monocytes collected in EDTA. 
For experiments using puriied monocyte subsets, cells were 
obtained from apheresis cones donated by anonymous platelet 
donors in Singapore. Blood samples and experimental procedures 
were approved by the Institutional Review Board, Singapore, 
in accordance to guidelines of the Health Science Authority of 
Singapore (Reference code: NUS-IRB10-250). Informed written 
consent was obtained from participants for this study in accord-
ance with the Declaration of Helsinki. Apheresis cones contain 
approximately 400–1,200 × 106 cells per cone, of which ~68% are 
lymphocytes, ~25% monocytes, ~5% neutrophils, ~2% basophils, 
and <1% eosinophils (45).
Monocyte Puriication
Human blood from apheresis cones was diluted 1:1 in Dulbecco’s 
phosphate bufered saline without Ca2+ and Mg2+ (Lonza). Diluted 
blood was separated on Ficoll-Paque PLUS (GE Healthcare Life 
Sciences) by centrifugation. he PBMC layer was removed and 
washed with saline to remove platelets. Red blood cells were 
lysed and cell number and viability determined by counting in 
the presence of Trypan Blue (Sigma-Aldrich). Total monocytes 
were positively selected using anti-CD14-beads according to 
manufacturer’s instructions (Miltenyi Biotec). he purity as 
determined by low cytometry, and viability by Trypan blue 
exclusion were consistently >90%. In some cases, monocytes 
were also puriied by adherence to plastic, as described previously 
(41). Monocytes for subsequent subset fractionation were irst 
enriched by depleting non-monocytic cells using magnet-acti-
vated cell sorting (MACS) with anti-CD3 and anti-CD19-beads, 
according to manufacturer’s instructions (Miltenyi Biotec). 
MACS-enriched monocytes contained typically 69% monocytes. 
For FACS puriication of monocyte subsets, a cocktail containing 
anti-CD14-eluor450 (eBioscience), anti-CD16-FITC (Miltenyi 
Biotec), and anti-CD56-APC (BD Biosciences) was added to the 
MACS-enriched total monocytes. Contaminating NK cells were 
excluded and monocyte subsets: Cl (~80%; CD14++CD16−), 
Int (~8%; CD14++CD16+), and NCl (~11%; CD14+CD16++) 
Abbreviations: ConA, concanavalin A lectin; MGC, multinucleated giant cell; Cl, 
classical monocyte sybset; NCl, non-classical monocyte subset; Int, intermediate 
monocyte subset; LGC, Langhans giant cell; SGC, syncytial giant cell; FBGC, 
foreign body giant cell; FI, fusion index; MACS, magnet-activated cell sorting; 
DC-STAMP, dendrocyte-expressed seven transmembrane protein; SEM, scanning 
electron microscopy; MFI, median luorescence intensity; MMP9, matrix metal-
lopeptidase 9.
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were gated based on the gating strategy shown in Figure S1 in 
Supplementary Material. To maintain reproducibility, subsets 
were always gated with equal sized square gates with perpendi-
cular borders. A post-sort check was conducted in every subset 
to ensure that the purity of each subset was ≥90%.
Fusion assays
FACS-puriied monocyte subsets were seeded at 1.5 × 105 cells per 
31.65 mm2 well to give a cell density of 4,739 monocytes mm−2. 
Within an hour of seeding, ConA from Canavalia ensiformis 
(Sigma-Aldrich) was added at 10  µg ml−1 in IMDM (Lonza) 
containing human AB Serum (Innovative Research, Inc., IPLA-
SERAB) and penicillin/streptomycin (Biological Industries). 
Monocyte subsets were incubated for up to 72 h at 37°C in 5% 
CO2 for all fusion assays. he supernatant from each well was 
collected and stored at −80°C for cytokine measurements. Cells 
were stained with nucleus/actin staining solution containing 
3 µg ml−1 DAPI (hermoFisher) and 1 µg ml−1 Phalloidin-TRITC 
(hermoFisher) overnight at 4°C in the dark. he cells were then 
ixed and imaged with an Olympus IX83 inverted microscope 
running MetaMorph for Olympus imaging sotware (Olympus, 
UK). MGC were identiied from the image Stack on FIJI ImageJ 
and freehand outlines were drawn around each MGC (deined 
as cells with ≥3 nuclei) to make Region Of Interest coordinates 
that could be saved alongside the Stack iles. he DAPI stack and 
ROI list ile were loaded in ImageJ before using a selection on 
user-generated macros to count the nuclei per MGC, MGC area 
and the total number of nuclei per ield. MGC types were desig-
nated using the criteria outlined in Figure S2 in Supplementary 
Material. LGC and FBGC are known types of MGC but a third 
category was also detected in our studies, which we termed the 
syncytial giant cell (SGC). SGC are characterized by having no 
clear organization of nuclei and with patchy staining for polymer-
ized actin (Figure S2 in Supplementary Material). In all cases, 
the total nuclei counted in single and fused cells were much 
lower than the number originally plated. he missing nuclei were 
designated as “Detached Cells” but the fate of these cells was not 
investigated further.
Measurement of Tetraspanin and Fusion 
Protein expression by Flow cytometry
A 10-marker panel was developed that could identify the three 
monocyte subsets, quantify the expression of seven tetraspa-
nins and detect cell viability all in one sample (Table S1A in 
Supplementary Material). he panel consisted of a LIVE/DEAD 
Blue dye, two monocyte subset markers (anti-CD14- PE-CF594 
and anti-CD16- PE-Vio770) and tetraspanins (anti-CD9-Biotin, 
anti-CD37-APC, anti-CD53-CF405M, anti-CD63-PerCP, anti-
CD81-Alexa Fluor 700, anti-CD82-PE, anti-CD151-FITC). 
Strepavidin-APC-Cy7 was used as the secondary reporter for 
CD9-Biotin. To detect changes ater ConA treatment, adher-
ent monocytes were treated with or without ConA for 4  h (at 
which point monocyte fusion can be observed), and then 
harvested by scraping prior to antibody staining, as above. 
A comp ensation matrix was generated on FACSDiva sotware 
using negative control or capture anti-mouse Fc compensation 
beads for all luorophore combinations. In separate experiments, 
fusion protein antibodies were used individually on freshly 
isolated monocytes, with a FITC-labeled secondary antibody, 
using the CD14/CD16 antibody pair to distinguish subsets. In all 
cases, antibodies were individually titrated to ascertain the con-
centration for optimum binding and compared to an appropriate 
isotype control antibody. Flow acquisition was performed on a 
BD LSR II.
Median nuclei per Mgc
he number of nuclei per MGC had a positive skew whereby 
smaller (3–8 nuclei) MGC were far more common than larger 
(≥20 nuclei) MGC and so the median was used to describe the 
average size of a giant cell in any given condition.
Fusion index (Fi)
Fusion index expresses the fusion of cells as the ratio of nuclei 
inside fused cells with ≥3 nuclei to the total number of nuclei 
counted and expressed as a percentage.
cytokine assays
he supernatants collected at 24, 48, and 72 h from the fusion 
studies were stored at −80°C before analysis for CCL2 (MCP-1), 
CCL3 (MIP-1α), RANTES, IL-1α, IL-1β, TNFα, IL-6, IL-17A, 
IL-4, IL-10, IL-13, GM-CSF, IL-3, IFNγ, and VEGF, using 
Luminex® xMAP® technology and customized human 9- and 
15-plex kits (Merck Millipore) with DropArray™-bead plates 
(Curiox).
scanning electron Microscopy (seM)
For imaging by SEM, sorted cells were allowed to adhere for 
15 min at room temperature to glass coverslips pretreated with 
poly-l-lysine (Sigma), then were ixed for 1 h at room temperature 
in 2.5% (w/v) glutaraldehyde and 0.1 M phosphate bufer (pH 7.4) 
and were washed twice in PBS. Ater ixation for 1  h at room 
temperature with 1% (w/v) osmium tetroxide (Ted Pella), cells 
were washed in deionized water and dehydrated with a graded 
series of ethanol immersions from 25 to 100%, and were dried to 
the critical point (CPD 030; Bal-Tec). he glass coverslip was then 
laid on adhesive ilm on a scanning electron microscope sample 
holder and was irmly touched with an adhesive sample holder. 
he surface on which the cells were deposited, as well as the adhe-
sive surface, were both coated with 5 nm of gold in a high-vacuum 
sputtering device (SCD005 sputter coater; Bal-Tec). he coated 
samples were examined with a ield emission scanning electron 
microscope (JSM-6701F; JEOL) at an acceleration voltage of 8 kV 
with the in-lens secondary electron detector. Fluorescence and 
brightield images were also taken and collaged into larger map 
images using ImageJ FIJI. he brightield map was compared with 
the low magniication SEM images to identify the location of the 
high magniication SEM images. he appropriate high magniica-
tion SEM images and 20× magniication luorescent images were 
then matched, cropped, and merged using ImageJ.
statistical analyses
All statistical analyses were performed with GraphPad Prism 
v6.04 and the appropriate tests are noted in the legend of each 
igure. In all igures the data value represents the number (n) of 
FigUre 1 | Cell fate during ConA­induced fusion varies between monocyte subsets. The fate of sorted monocyte subsets was determined by counting nuclei at 24, 
48, and 72 h and expressed as a percentage of the cell numbers originally plated. Bars represent means ± SEM, n = 8. Signiicance was tested with a Kruskal–
Wallis test with a Dunn’s multiple comparisons test comparing the means of the same fate and time point against the other subsets. Black bars/red error bars: 
detached cells, gray bars/green error bars: single cells and white bars/blue error bars: fused cells with >3 nuclei.
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diferent donor repeats in the experiment, and the SEM is reported 
where n ≥ 3, except where stated. All luorescence-based values 
[low cytometry median luorescence intensity (MFI)] were log- 
transformed before statistical analysis. *p ≤  0.05, **p ≤  0.01, 
***p ≤ 0.001, ****p ≤ 0.0001.
resUlTs
Monocyte subsets and Mgc Formation
Human blood monocytes were irst negatively selected by 
removing non-monocytic cells using MACS and then subjected 
to positive selection for individual subsets using stringent gating 
based on anti-CD14 and anti-CD16 antibody binding (Figure S1 
in Supplementary Material).
Fusion was induced using ConA, a lectin known to stimulate cell 
fusion in diverse cell types, e.g., Drosophila somatic cells (46). he 
exact mechanism of ConA facilitated fusion is currently unknown. 
However, it has been shown that ConA triggers a release of fusion 
initiating cytokines from mouse macrophages, such as IFNγ, TNF-
α, IL-1β, and IL-4 (47). he behavior of the diferent subsets during 
ConA stimulation was determined by counting stained nuclei to 
provide a measure of the proportions of single and fused cells where 
the latter refers to cells with >3 nuclei (Figure 1). Interestingly, the 
majority of the monocytes were lost ater 72 h, presumably due to 
detachment and/or cell death. Int monocytes fused more rapidly 
than Cl and NCl subsets, but were also signiicantly more likely to 
be dead/detached by 48 and 72 h. Cl monocytes were signiicantly 
less likely to fuse than either of the other two subsets, although 
the diferences between subsets became less pronounced over time.
FigUre 2 | Fusion in different monocyte subsets imaged by tandem luorescent scanning electron microscopy (SEM) and wide ield luorescence microscopy. 
(a–c) left panels. monocyte­derived giant cell (MGC) were generated by 72­h concanavalin A (ConA) treatment of FACS­sorted monocyte subsets, stained  
with Hoechst and then raster­scanned so that the MGC imaged in SEM could be located and the nuclear channel overlaid onto the image. Nuclei shown in  
blue. (a–c) right panels. Three representative montages containing images taken of each of the monocyte subsets from one donor after 72 h ConA treatment. 
Blue = F­actin, Red = nuclei. (a) classical, (B) intermediate, (c) non­classical subset­derived MGC.
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FigUre 3 | Fusion parameters vary between monocyte puriication method and between subsets. (a–c) Unfractionated monocytes, puriied by magnet­activated 
cell sorting (MACS) or adherence were incubated for 72 h with concanavalin A (ConA) to induce fusion. After luorescence imaging, three parameters of monocyte­
derived giant cell (MGC) were recorded: median number of nuclei/MGC, fusion index (FI), and median area occupied by each MGC. Signiicance was tested using 
an unpaired t­test. (D–F) Monocytes sorted into subsets by FACS were incubated for 72 h with ConA to induce fusion. After luorescence imaging, three parameters 
of MGC were recorded: median number of nuclei/MGC, FI and median area occupied by each MGC. Signiicance was tested with a Kruskal–Wallis test with  
a Dunn’s multiple comparisons test. (g–i) After 24, 48, and 72 h incubation with ConA, the proportions of each type of MGC were recorded and presented as  
a percentage of the total fused nuclei counted. Bars represent means ± SEM, n = 8. Signiicance was tested with a Kruskal–Wallis test with a Dunn’ multiple 
comparisons test comparing the means of the same MGC type within the same time point against the other subset means. Black bars/red error bars: Langhans 
giant cell, gray bars/green error bars: FBGC and white bars/blue error bars: syncitial giant cell (SGC).
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he MGC were classiied as LGC, FBGC, or SGC based on the 
arrangement of nuclei within each MGC according to the criteria 
shown in Figure S2 in Supplementary Material. Representative 
wide ield and tandem luorescence-SEM images of fused mono-
cytes formed ater 72 h are shown for each subset in Figure 2. 
here are distinct diferences in the sizes and morphologies of 
the MGC (Figure 2), suggesting subset-speciic factors in MGC 
formation. Interestingly, the monocyte puriication method, 
i.e. adherence or positive puriication by MACS using anti-CD14 
strongly afected MGC formation in response to ConA. Despite 
a similar median number of nuclei observed per MGC, MACS-
puriied monocytes formed signiicantly larger MGC than 
FigUre 4 | Tetraspanin expression varies between monocyte subsets. Monocytes were either freshly sorted into subsets by FACS, or were puriied then allowed to 
adhere, incubated for 4 h with concanavalin A (ConA) to induce fusion and then harvested, before being tested for the expression of a panel of common myeloid cell 
tetraspanins using low cytometry. (a) Freshly puriied monocyte subsets, expression level per cell (MFI). (B) Freshly puriied monocyte subsets, percentage of the 
cell population with expression above isotype control binding levels. (c) Adherent, ConA treated monocytes, expression level per cell (MFI). (D) Adherent, ConA 
treated monocytes, percentage of the cell population with expression above isotype control binding levels. The data are the means ± SEM of monocytes from four 
donors. For (a,B), signiicance was tested by two­way ANOVA and a Tukey multiple comparison test. For (c,D), signiicance was tested with multiple t tests with 
Benjami, Krieger, and Yekutieli false discovery rate approach and Holme–Sidak multiple comparisons.
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adherence-puriied monocytes, as determined by the median 
area and FI (Figures 3A–C).
he physical parameters of the MGC formed by monocyte 
subsets were assessed at 72  h. FI is signiicantly higher for Int 
relative to Cl monocytes, as is the median number of nuclei per 
MGC (Figures 3D–F), while Int and NCl subsets were similar 
for both measurements. Interestingly, the median area covered 
by each MGC is higher for Int monocytes relative to the other 
two subsets, perhaps related to the higher percentages of FBGC 
and SGC observed in Int cultures (Figures 3G,H). At 24 h, the Int 
monocytes formed signiicantly more SGC (Figure 3G) whereas 
at 48 h of ConA stimulation, they were signiicantly less likely to 
form LGC than Cl monocytes (Figure 3H). By 72 h, no signiicant 
diference in the types of MGC formed was observed between 
the subsets (Figure 3I). hus, there are quantitative diferences 
between the MGC formed by the subsets, in terms of the kinetics 
of fusion, the sizes, and morphologies of the MGC formed.
Tetraspanin expression on Monocyte 
subsets
Tetraspanins, particularly CD9, CD81, CD151, and CD63, have 
been associated with cell fusion in monocytes, developing muscle, 
and during fertilization (43). We therefore measured the plasma 
membrane expression of seven common tetraspanins in the freshly 
puriied subsets (Figures 4A,B). he surface expression of tetras-
panins on the monocyte subsets shows wide variation, with CD9 
and CD37 signiicantly more highly expressed in the Int subset, 
in terms of absolute expression levels (MFI) and CD37 is more 
widely expressed in Int monocytes when expressed as a percentage 
of the population of cells. Ater 4 h ConA treatment of adherent 
monocytes, the expression of all of some of the tetraspanins (CD53, 
CD82, and in percent positive cells, CD37) declines (Figures 4C,D). 
In terms of the expression per cell, the MFI values for CD53 and 
CD82 decrease signiicantly in all subsets. Interestingly, expression 
of CD9, oten thought to be a negative regulator of fusion and so 
expected to decrease ater ConA treatment, showed no signiicant 
changes in any of the subsets (Figures 4C,D). We also identiied a 
population of CD9High cells in the unstimulated Cl subset. Typically, 
~75% of Cl monocytes were CD9Low and ~23% CD9High (Figure 5A). 
Examining the co-expression of other tetraspanins with CD9, the 
dot-plots show an apparent degree of correlation and statistical 
analysis conirms that CD151 is signiicantly elevated in CD9High 
Cl monocytes (Figures 5B,C). However, when sorted, CD9High Cl 
monocytes did not show a diferent ability to fuse compared to 
CD9Low Cl monocytes (data not shown).
effects of anti-Tetraspanin antibodies on 
Mgc Formation
Anti-tetraspanin antibodies have previously been shown to either 
positively (anti-CD9, anti-CD81) or negatively (anti-CD63, anti- 
CD151) affect the size of MGC formed by fusing monocytes 
(40–42), although the contribution of the diferent subsets and 
FigUre 5 | A tetraspanin CD9High subset of classical monocytes. (a) Histograms showing the expression of CD9 on freshly isolated classical (Cl), intermediate  
(Int), and non­classical (NCl) monocyte subsets from a representative donor, with isotype control luorescence shown as shaded areas. The gating strategy to 
separate the CD9High and CD9Low populations is indicated by the markers. CD9 was the only tetraspanin in the histograms to show a bimodal peak of expression.  
(B) Dot­plots showing the surface co­expression of tetraspanins on classical subset monocytes with CD9 from a representative donor. Increasing expression of CD9 
is indicated by the blue shading. (c) Quantiication of tetraspanin expression on Cl subset monocytes gated for CD9 high and low expression as shown in panel A. 
Bars represent the means ± SEM, from 10 different donors. Signiicance was tested using one­way ANOVA with Sidak’s multiple comparisons test for each pair of 
columns.
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the types of MGC formed have not been analyzed before. Here, 
we have used a range of anti-tetraspanin antibodies to investigate 
their contribution to subset- and MGC type speciic efects during 
monocyte fusion (Table S1B in Supplementary Material). First, 
we investigated the efects of antibodies on the fate of seeded cells 
(Figure 6). None of the tetraspanin antibodies caused a signiicant 
increase in cell detachment, suggesting that any efects on fusion 
were not caused by changes in cellular adherence or survival. 
However, several antibodies (against CD9, CD53, CD63, and 
CD151) did show a trend toward increased cell detachment.
Strikingly, the proportions of each type of MGC produced by 
fusion of Int monocytes were changed by the anti-tetraspanin 
antibodies used here (Figure 7) whereas Cl and NCl subsets were 
not afected. Anti-CD63, in particular caused signiicant changes 
in the proportions of MGC formed. It inhibited SGC formation 
completely and promoted a much higher proportion of LGC to 
FBGC. Anti-CD9, anti-CD53, and anti-CD151 antibodies exhib-
ited similar efects but the changes did not reach signiicance. Total 
(unseparated) MACS-puriied monocytes were also signiicantly 
afected by only anti-CD63. Anti-CD37 antibody also showed 
a trend toward the inhibition of SGC formation in Cl and NCl 
monocytes. Interestingly, the proportions of the various MGC 
types formed by unfractionated monocytes did not resemble 
those formed by the isolated subsets, suggesting that interactions 
between the monocyte subsets can also afect the type of MGC 
formed (Figure 7). he adherence-puriied monocytes responded 
only to anti-CD9 antibodies, with higher proportions of larger 
FBGC and SGC (Figure S3 in Supplementary Material).
With respect to the sizes of the MGC formed, only Int mono-
cytes were afected by treatment with anti-tetraspanin antibodies. 
FigUre 6 | Anti­tetraspanin antibodies do not affect cell fate during concanavalin A (ConA)­induced fusion. The fate of sorted monocyte subsets was determined 
by counting nuclei at 72 h and expressed as a percentage of the cell numbers originally plated. Bars represent means ± SEM, n = 3–8. Signiicance was tested with 
a Kruskal–Wallis test with Dunn’s multiple comparisons test comparing the means of the same state within the same time point against the other subsets. Black 
bars/red error bars: detached cells, gray bars/green error bars: single cells and white bars/blue error bars: fused cells with >3 nuclei.
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In contrast to previous data on total monocytes puriied by adher-
ence (40, 41) and as shown here in Figure S3 in Supplementary 
Material, anti-CD9 antibodies did not cause an increase in MGC 
size and have no signiicant efects on either FI or the number 
of nuclei per MGC on any of the monocyte subsets. However, 
anti-CD63 antibodies were found to be consistently inhibitory 
on all parameters of Int fusion (Figure 8). Anti-CD151 antibody 
also caused a signiicant decrease in MGC median area whereas 
anti-CD53 also inhibited MGC formation but this did not reach 
signiicance, p = 0.056.
expression of Fusion-related Molecules 
on Monocyte subsets
Many molecules have been associated with monocyte fusion 
(26–33) and so we examined a panel of 10 membrane proteins for 
diferential expression on the unstimulated subsets. Int monocytes 
were clearly enriched for a number of these, including DC-STAMP, 
CD98 CD17a, and CD200 relative to one or both of the other sub-
sets (Figure 9). his overall pattern of fusion molecule expression 
might explain the greater propensity of the Int subset to undergo 
ConA-stimulated fusion.
cytokine expression in Fusing Monocytes
To further investigate the mechanism behind the greater fuso-
genicity of Int monocytes, we analyzed cytokine production 
during ConA-mediated fusion to determine if fusogenic cytokine 
production could contribute to this. ConA-stimulated cytokine 
production was signiicantly higher in Int monocytes for IL-1α 
and IL-1β, conirming the higher pro-inlammatory capacity 
of this subset (Figure 10). However, other cytokines previously 
identiied as being pro-fusogenic, such as CCL2, IL-4 and IL-13, 
were not elevated in cultures of Int monocytes when compared to 
FigUre 7 | Anti­CD63 antibodies can modulate giant cell morphology only in the intermediate monocyte subset. Puriied monocyte subsets were cultured in media 
containing concanavalin A (ConA) and either an anti­tetraspanin antibody or IgG1 control at 10 µg ml−1 for 72 h. Nuclei counted inside each monocyte­derived giant 
cell (MGC) were ascribed to one of the giant cell types and presented as a percentage of the fused nuclei counted. Bars represent means ± SEM, n = 3–8, tested 
with a Kruskal–Wallis test with Dunn’s multiple comparisons tests comparing the same MGC types between the anti­tetraspanin conditions and the IgG1 control. 
Black bars/red error bars: Langhans giant cell, gray bars/green error bars: foreign body giant cell and white bars/blue error bars: SGC.
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the other two subsets. hus, the Int monocytes appear to gener-
ally secrete higher levels of cytokines but no particular cytokine 
(of those measured) can be described as playing a pivotal role in 
the control of MGC formation. IFNγ, IL-10, IL-17A, CCL5, and 
VEGF were also tested but were either not detected or were not 
signiicantly diferent from unstimulated controls.
DiscUssiOn
Here, we demonstrate for the irst time that human monocyte 
subsets show very diferent propensities to form MGC in response 
to ConA stimulation. he Int subset fused faster and formed more 
of the larger FBGC and SGC types while the Cl fused to form 
mostly the smaller LGC.
Monocyte Puriication Methods
Previous studies on the role of tetraspanins in ConA-induced 
monocyte fusion used cells puriied by adherence (40, 41), which 
have a very diferent pattern of fusion and anti-tetraspanin 
antibody sensitivity to the MACS-puriied total monocytes 
used in this report (Figures 3 and 7; Figure S3 in Supplementary 
Material). he MACS technique speciically enriches monocytes 
whereas the adherence method relies on the ability of cells to 
rapidly adhere to plastic surfaces and some contaminating T 
FigUre 8 | Anti­tetraspanin antibodies inhibit fusion rate and size of giant cells produced by intermediate monocyte subset. Puriied monocyte subsets were 
cultured in media containing (ConA) and either an anti­tetraspanin antibody or IgG1 control at 10 µg ml−1 for 72 h. Bars represent means ± SEM, of 3–8 separate 
experiments. Signiicance was tested with a Kruskal–Wallis test and a Dunn’s multiple comparisons test comparing the anti­tetraspanin antibody means against the 
IgG1 control within each subset.
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and NK cells may be present. In addition, Int and NCl subsets 
are less adherent than Cl within the irst 24  h ater isolation, 
and so in the previous studies more of the initially adherent 
low-fusing Cl and fewer of the high-fusing Int and NC subsets 
may have been present. Although Int were observed to be the 
most fusogenic of the subsets (Figure 3A), total MACS-puriied 
monocytes stimulated with ConA showed even higher fusion 
parameters with many more FBGC and SGC (Figure 7). his 
suggests that fusion potency is increased by interaction between 
the subsets.
Monocytes subsets and Fusion
he histological type of MGC formed by each subset has been 
quantiied, with the Int and NCl showing a greater capacity to 
form the larger FBGC and SGC types. his has implications for 
the treatment of medical implant rejection as it is clearly the Int 
and NCl subsets that form the larger MGC associated with for-
eign body rejection. Interestingly, the Int subset is increased in 
the blood of sarcoidosis patients (15), a condition characterized 
by granulomas in which FBGC and LGC are present (48). he 
increased ability of the Cl subset to form LGC could indicate 
that they are specialized in responding to mycobacterial infec-
tions, as LGC are commonly found in granulomatous infections 
in vivo (19).
Tetraspanin expression on subsets
Our data for the expression of CD9, CD53, CD63, and CD81 does 
not correlate directly with that of Tippett and co-workers (44), who 
observed higher percentages of cells expressing CD9 and CD63 
overall in each subset. Furthermore, they ranked the intensity 
of surface expression of CD9 on the subsets as Cl > Int > NCl, 
CD53 as NCl > Int > Cl, and CD81 as NCl > Int > Cl, whereas 
here all three tetraspanins were found to be highest on the Int 
subset. However, the CD14/CD16 gating strategy used by Tipett 
and co-workers may not have been as stringent as here and so 
the distinction between the subsets may be less clear. In addition, 
they did not mention any techniques to remove CD16+ NK cells, 
which overlap with NCl in CD14+/CD16+ populations. Overall, 
we found the Int subset expressed the highest levels of all tetras-
panins in freshly puriied monocytes except for CD82, which 
was signiicantly higher in the Cl subset. he addition of ConA 
induced signiicant decreases in the level of CD53 and CD82 and 
a decrease in the percentage of cells expressing CD37, CD53, 
and CD82. It appears that ConA induces rapid downregulation 
of these tetraspanins from the cell surface, although there is 
no obvious correlation with fusion. Other tetraspanins impli-
cated in fusion, such as Tspan13 and Tspan5, show decreased 
or increased expression, respectively, in response to RANKL 
stimulation (39). Tarrant and co-workers (49) showed that 
FigUre 9 | The expression of fusion­related molecules is higher on intermediate monocyte subset. Freshly isolated monocytes were analyzed for fusion protein 
expression on subsets using low cytometry. Bars indicate means ± SD from three separate experiments. Signiicance of difference between subsets was tested 
with a one­way ANOVA and a Tukey multiple comparisons test.
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Tspan32 knockout mice produced T-cells that became hyper-
stimulated by ConA. In future studies, it would be interesting 
to investigate the efects of ConA on further members of the 
tetraspanin family. he Cl monocyte subset showed an intrigu-
ing bimodal expression of CD9, with nearly 25% of this subset 
(and thus ~20% of total monocytes) having a signiicantly higher 
FigUre 10 | Cytokine production proiles during fusion do not correlate with fusion rate or giant cell morphology. Supernatants from the fusing monocytes were 
collected and analyzed by ELISA for 15 cytokines relevant to fusion. Clear bars: control (NA), striped bars: concanavalin A (ConA) treated; with each time point [24 
(red), 48 (purple), 72 h (green)] presented in adjacent pairs. Bars represent means ± SEM, from eight separate experiments, all tested for signiicance with a two­ 
way ANOVA with a Sidak’s multiple comparison test comparing the means of control (NA) vs ConA treated monocytes at the same time point within each subset.
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surface expression of this tetraspanin. Co-expression analysis of 
the tetraspanins showed a positive correlation between CD9 and 
CD151 expression on Cl. While CD9High Cl showed no increase 
in fusion potential, it would be interesting in future work to 
investigate other functions of these cells, such as their propensity 
for extravasation.
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anti-Tetraspanin antibodies and Fusion
he Int subset showed clear signiicant decreases in fusion para-
meters and MGC types produced when cultured in the presence of 
anti-CD63. Anti-CD63 also signiicantly inhibited MGC forma-
tion by total MACS-puriied monocytes in response to ConA, in 
agreement with previous data (41). No inhibition by anti-CD63 
was observed for the Cl and NCl subsets, however, suggesting that 
fusion may be orchestrated diferently in the subsets. It is also pos-
sible that the lower baseline fusion rates of Cl and the NCl subsets 
could be masking any notable reductions by these antibodies. It is 
not clear from the present work if anti-CD63 treatment is directly 
afecting cell fusion. CD63 knockdown causes arrested motility 
due to decreased actin polymerization by engaged E-cadherin 
(50). herefore, it is possible that the decrease in fusion is a result of 
arrested mobility and not interference with the fusion mechanism. 
he lack of a change in the expression level of CD63 during ConA 
stimulation suggests that antibody might be modulating function 
by sequestering CD63 away from partner proteins, for example, 
or by clustering molecules together to activate signaling. Further 
work is required to distinguish between these possibilities.
Interestingly, antibodies against CD9, CD53, CD63, and CD151 
did show a trend toward increased cell detachment in the NCl subset 
and this pattern was also seen in the efects on Int subset MGC types. 
his suggests that these tetraspanins might have a role in monocyte 
behavior but that antibodies are not ideal tools to study this role.
Fusion-related Membrane Proteins
We hypothesized that increased fusion and sensitivity to anti-
CD63 antibody in the Int subset might be due to changes in the 
expression of membrane proteins known to play a role in fusion, 
many of which are also known to be partners of tetraspanins. he 
high-fusing Int monocytes showed generally high levels of the 
fusion-mediating molecules DC-STAMP, CD172a, CD200, and 
CD62E and low levels of MMP9 and CD36 relative to the other 
subsets. DC-STAMP, the only molecule signiicantly higher in Int 
than in both of the other subsets, has been shown to be essential 
for cell–cell fusion in osteoclasts and FBGCs (32, 33). CD200, 
signiicantly higher in Int than Cl, is expressed in monocytes 
ater the induction of fusion (26). SIRPα/CD172a/MFR, also 
higher in Int than Cl, has been shown to be essential for MGC 
formation (27). MMP9 has been shown to be involved in mouse 
MGC formation in vivo and in response to IL-4 in vitro (31) but 
was found here to be signiicantly lower in Int monocytes than 
in Cl. CD36, a phosphatidylserine and lipid binding protein, has 
been shown to have a role in cytokine-induced MGC but not 
in osteoclast generation (29). Cl and Int monocytes had higher 
levels of CD36 than NCl, but as Cl and NCl have similarly low 
fusogenic potential, this suggests that CD36 expression is not 
speciically related to higher fusion rates in the Int subset. CD62E 
(E-selectin) has been implicated in osteoclast formation (51) and 
MGC formation driven by B. pseudomallei infection of U937 
cells (30). While it is not signiicantly more highly expressed 
in Int monocytes than Cl, CD62E is expressed at a similar level 
on the lower fusing NCl monocytes. Taken together, however, 
our data indicate that diferences in the expression of multiple 
fusion-related molecules might be related to the greater fusion 
capacity of Int monocytes.
cytokine Production During Fusion
We hypothesized that diferent levels of cytokine production 
during ConA stimulation might play a role in the diferences in 
fusion between subsets but the lack of a clear pattern suggests that 
this is not the primary driver of the variation between monocyte 
subsets. However, the subsets do show remarkably diferent 
cytokine proiles during fusion. he Int and Cl secreted pro-
apoptotic cytokines (TNFα) within the irst 24 h followed by an 
increase in pro-inlammatory cytokines (IL-1α, IL-1β, and IL-6) 
by 48 h. IL-1α and IL-1β have been shown to be released from cells 
undergoing apoptosis (52) and we also observed at these same 
time points that a large number of monocytes (57–65%) were 
dead or detached. his could suggest that many ConA-stimulated 
monocytes undergo apoptosis and the release of internal IL-1 is a 
necessary step to generate the fusogenic cytokines. However, the 
NCl subset achieved greater fusion rates than the Cl monocytes 
but did not release high levels of IL-1α, IL-1β, or TNFα, suggesting 
that apoptosis of some cell types is not a pre-requisite for fusion.
In summary, we have shown that the various monocyte sub-
sets difer in their capacity to form MGC in response to ConA, 
with the Int subset showing greatest propensity for fusion. For 
this subset, there is evidence that the tetraspanin CD63 may 
be involved in the process. It is interesting to speculate that the 
increased fusogenic potential of Int moncytes may relate to their 
roles in granuloma formation in infectious and inlammatory 
conditions in vivo.
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FigUre s1 | FACS gating strategy of monocyte subsets from magnet­activated 
cell sorting­enriched fraction. Pseudocolour/contour plots showing the FACS 
gating strategy for sorting monocyte subsets. First, monocytes were broadly 
selected by their forward and side scatter proiles followed by singlet gating. 
NK cells were removed by selecting for CD56− cells. Second, CD14++CD16− 
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(Classical), CD14++CD16+ (Intermediate), and CD14+CD16+ (non­classical) 
monocytes were gated as shown and sorted. The purity of the sorted 
populations was always >90%.
FigUre s2 | Morphologies of the three monocyte­derived giant cell (MGC) 
types observed during fusion assays. A representative low magniication image 
with nuclei in red and F­actin in blue. Langhans giant cells can be identiied by 
their horseshoe or ring­shaped nuclear arrangement and are typically the 
smallest. Foreign body giant cells (FBGC) are larger and contain more nuclei  
in a stacked central cluster. Syncytial giant cells (SGC) are the largest, have 
heterogeneous spreading of the membrane and unevenly distributed nuclei 
within.
FigUre s3 | Monocyte­derived giant cell (MGC) types generated from adherence­
puriied total monocytes. The MGC types generated from total monocytes puriied  
by adhesion cultured for 72 h in concanavalin A (ConA) media and corresponding 
anti­tetraspanin antibody. Fused nuclei were tallied into either Langhans giant cell, 
FBGC, or SGC depending on what MGC type they were found in and expressed as 
a percentage of all fused nuclei. Bars represent the mean ± SEM, with data from four 
separate experiments. Tested with a Dunn’s multiple comparison test; comparing the 
mean ranks of each MGC type to the IgG1 + ConA control (*p < 0.05).
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